Parkinson's Disease

Alpha-synuclein as a therapeutic target for Parkinson’s disease 2:26
Alpha-synuclein as a therapeutic target for Parkinson’s disease
Gennaro Pagano • 5 Nov 2021
Searching for therapeutic targets for Parkinson’s disease 1:32
Searching for therapeutic targets for Parkinson’s disease
Gennaro Pagano • 5 Nov 2021
Therapeutic approaches to target alpha-synuclein in Parkinson’s disease 1:46
Therapeutic approaches to target alpha-synuclein in Parkinson’s disease
Gennaro Pagano • 5 Nov 2021
Future prospects in Parkinson’s disease 1:00
Future prospects in Parkinson’s disease
Gennaro Pagano • 5 Nov 2021
Questioning the Braak hypothesis in Parkinson’s disease 3:42
Questioning the Braak hypothesis in Parkinson’s disease
Alberto Espay • 9 Sep 2021
Is clearing α-synuclein enough to treat Parkinson’s disease? 2:49
Is clearing α-synuclein enough to treat Parkinson’s disease?
Alberto Espay • 9 Sep 2021
REPAIR-MS and REPAIR-PD: tackling disease progression with gold nanocrystals 8:23
REPAIR-MS and REPAIR-PD: tackling disease progression with gold nanocrystals
Robert Glanzman • 13 Oct 2021
Connectomic DBS: target discovery based on neuronal circuitry 2:25
Connectomic DBS: target discovery based on neuronal circuitry
Michael Fox • 29 Sep 2021
Similarities between the gut microbiome in Parkinson’s disease & MS 0:46
Similarities between the gut microbiome in Parkinson’s disease & MS
Paul Wilmes • 5 Oct 2021
Analysis of neurotransmitter metabolites in CSF in Parkinson’s Disease 1:19
Analysis of neurotransmitter metabolites in CSF in Parkinson’s Disease
Brit Mollenhauer • 24 Sep 2021
Time is brain in Parkinson’s disease 1:19
Time is brain in Parkinson’s disease
Brit Mollenhauer • 24 Sep 2021
Non-invasive spinal cord stimulation in Parkinson’s disease 3:45
Non-invasive spinal cord stimulation in Parkinson’s disease
Rubens Gisbert Cury • 27 Sep 2021
Environmental and genetic interactions in the pathogenesis of Parkinson’s disease 2:28
Environmental and genetic interactions in the pathogenesis of Parkinson’s disease
Caroline Tanner • 14 Sep 2021
How can we advance DBS? Moving towards connectomic modulation 6:00
How can we advance DBS? Moving towards connectomic modulation
Michael Fox • 29 Sep 2021
PD_PAL: developing new standards of palliative care in Parkinson’s disease 1:26
PD_PAL: developing new standards of palliative care in Parkinson’s disease
Victor McConvey • 13 Sep 2021
Non-invasive stimulation to treat Parkinson’s disease: ongoing research 2:28
Non-invasive stimulation to treat Parkinson’s disease: ongoing research
Rubens Gisbert Cury • 27 Sep 2021
The content of VJNeurology is intended for healthcare professionals